Wenhai Deng

9PUBLICATIONS
40CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 18, 2025
Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial.

Wen Lei, Hui Liu, Wenhai Deng

|Feb 14, 2025
An integrated multi-omics analysis identifies protein biomarkers and potential drug targets for psoriatic arthritis.

Yi-Xin Cai, Dai-Shan Zheng, Xiao-Li Chen

|Apr 02, 2024
CD70-specific CAR NK cells expressing IL-15 for the treatment of CD19-negative B-cell malignancy.

Shanshan Guo, Wen Lei, Xueli Jin

|Mar 02, 2024
Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy.

Xufeng Lu, Xiaodong Chen, Chengyin Lin

|Oct 05, 2022
Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression.

Xufeng Lu, Dazhuan E Xin, Juanjuan K Du

|Jul 19, 2019
Efficient CD4Cre-Mediated Conditional KRas Expression in Alveolar Macrophages and Alveolar Epithelial Cells Causes Fatal Hyperproliferative Pneumonitis.

Pengcheng Chen, Shang Wang, Kyathanahalli S Janardhan

Pageof 2

Frequent Collaborators

5 joint publications

Wenbin Qian

3 joint publications

Hui Liu

2 joint publications

Yi Eve Sun

2 joint publications

Aibin Liang